About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 821641, 8 pages
http://dx.doi.org/10.1155/2012/821641
Research Article

Clinical Pathways Based on Integrative Medicine in Chinese Hospitals Improve Treatment Outcomes for Patients with Acute Myocardial Infarction: A Multicentre, Nonrandomized Historically Controlled Trial

1Intensive Care Unit (ICU), Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou 510120, China
2Intensive Care Unit (ICU), 2nd Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou 510120, China
3Yueyang Hospital of Integrated Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China
43rd Affiliated Hospital, Guangxi College Traditional Chinese Medicine, Guangxi 545001, China
5Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200021, China
6Wuyi Hospital of Traditional Chinese Medicine, Jiangmen, Guangdong 200021, China
7Oriental Hospital, Beijing University of Traditional Chinese Medicine, Beijing 100078, China
8Zhongshan Hospital of Traditional Chinese Medicine, Zhongshan, Guangdong 528400, China
9Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing, Jiangsu 210029, China
10Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA

Received 5 March 2012; Revised 22 July 2012; Accepted 1 August 2012

Academic Editor: Andreas Michalsen

Copyright © 2012 Lei Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. W. Yeh, S. Sidney, M. Chandra, M. Sorel, J. V. Selby, and A. S. Go, “Population trends in the incidence and outcomes of acute myocardial infarction,” The New England Journal of Medicine, vol. 362, no. 23, pp. 2155–2165, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Moran, D. Gu, D. Zhao et al., “Future cardiovascular disease in China Markov model and risk factor scenario projections from the coronary heart disease policy model-China,” Circulation, vol. 3, no. 3, pp. 243–252, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Gao, A. Patel, W. Gao et al., “Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes,” Heart, vol. 94, no. 5, pp. 554–560, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. H. X. Liu, S. R. Wang, Y. Lei, and J. J. Shang, “Characteristics and advantages of traditional Chinese medicine in the treatment of acute myocardial infarction,” Journal of Traditional Chinese Medicine, vol. 31, no. 4, pp. 269–272, 2011.
  5. J. J. Shang, H. Shi, Q. Zhou, W. Gao, and H. X. Liu, “A study of prognosis, outcome, and changing tendency of hospitalized AMI patients in Beijing third-grade A-level traditional Chinese medicine hospitals from 1999 to 2008,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 837194, 6 pages, 2012. View at Publisher · View at Google Scholar
  6. N. R. Every, J. Hochman, R. Becker, S. Kopecky, and C. P. Cannon, “Critical pathways: a review,” Circulation, vol. 101, no. 4, pp. 461–465, 2000. View at Scopus
  7. J. P. Liu, S. C. Wang, D. R. Wu, et al., “Establishment and implementation of evidence-based clinical pathway of Chinese medicine,” Zhongguo Zhongxi Jiehe Zazhi, vol. 31, no. 1, pp. 115–119, 2011.
  8. M. C. Bahit, S. A. Murphy, C. M. Gibson, and C. P. Cannon, “Critical pathway for acute ST-segment elevation myocardial infarction: estimating its potential impact in the TIMI 9 Registry,” Critical Pathways in Cardiology, vol. 1, no. 2, pp. 107–112, 2002.
  9. L. Wang, M. Z. Zhang, G. Yang, et al., “Establishment and testing practice of an integrative medical pathway for clinical management of acute myocardial infarction,” Zhongguo Zhongxi Jiehe Zazhi, vol. 31, no. 1, pp. 7–10, 2011.
  10. J. Zhang, X. J. Zhao, L. Wang, et al., “Construction and evaluation of integrative medical pathway for acute myocardial infarction,” Journal of Clinical Research, vol. 28, no. 8, pp. 1554–1555, 2012.
  11. L. Wang, J. Z. He, J. Zhang, et al., “An approach to law of distribution and evolvement of syndrome elements during peri-reperfusion period on 218 patients with acute myocardial infarction,” Zhongguo Zhong Xi Yi Jie He Ji Jiu Za Zhi, vol. 17, no. 5, pp. 267–269, 2010.
  12. Branch of Cardiovasology of Chinese Association of Integrative Medicine, “Traditional Chinese medicine syndrome differentiation standards of coronary heart diseases,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 11, no. 5, p. 257, 1991.
  13. Y. D. Chen, X. T. Song, S. Z. Lv, et al., “Evaluation of various therapies in patients with acute ST segment elevation myocardial infarction who arrived at hospitals within 12 hours from the onset of chest pain,” Chinese Journal of Interventional Cardiology, vol. 13, no. 1, pp. 5–8, 2005.
  14. E. M. Antman, M. Hand, P. W. Armstrong, et al., “2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the american college of cardiology/american heart association task force on practice guidelines: developed in collaboration with the canadian cardiovascular society endorsed by the american academy of family physicians: 2007 writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 writing committee,” Circulation, vol. 117, no. 6, pp. 296–329, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. Ministry of Health, “Clinical pathways of ST-segment elevation myocardial infarction (2009 version),” 2009, http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohyzs/s3585/200907/41676.htm.
  16. W. C. M. Yip, W. Hsiao, Q. Meng, W. Chen, and X. Sun, “Realignment of incentives for health-care providers in China,” The Lancet, vol. 375, no. 9720, pp. 1120–1130, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. C. Bahit, S. A. Murphy, C. M. Gibson, and C. P. Cannon, “Critical pathway for acute ST-segment elevation myocardial infarction: estimating its potential impact in the TIMI 9 Registry,” Critical Pathways in Cardiology, vol. 1, no. 2, pp. 107–112, 2002.
  18. S. Hu, S. Tang, Y. Liu, Y. Zhao, M. L. Escobar, and D. de Ferranti, “Reform of how health care is paid for in China: challenges and opportunities,” The Lancet, vol. 372, no. 9652, pp. 1846–1853, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Bi, R. Gao, A. Patel et al., “Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the clinical pathways for acute coronary syndromes in China (CPACS) study,” American Heart Journal, vol. 157, no. 3, pp. 509–516, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. H. X. Liu, W. Gao, D. Zhao, and J. J. Shang, “Survey on the hospitalization treatment status of acute myocardial infarction patients in 13 hospitals of Western medicine and traditional Chinese medicine in Beijing,” Zhonghua Xin Xue Guan Bing Za Zhi, vol. 38, no. 4, pp. 306–310, 2010.
  21. Z. Y. Gao, H. Xu, D. Z. Shi, C. Wen, and B. Y. Liu, “Analysis on outcome of 5284 patients with coronary artery disease: the role of integrative medicine,” Journal of Ethnopharmacology, vol. 141, no. 2, pp. 578–583, 2012.
  22. J. G. Zhang, D. S. Gao, and G. H. Wei, “Clinical study on effect of Astragalus injection on left ventricular remodeling and left ventricular function in patients with acute myocardial infarction,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 22, no. 5, pp. 346–348, 2002. View at Scopus
  23. R. Zhou, L. F. He, Y. J. Li, Y. Shen, R. B. Chao, and J. R. Du, “Cardioprotective effect of water and ethanol extract of Salvia miltiorrhiza in an experimental model of myocardial infarction,” Journal of Ethnopharmacology, vol. 139, no. 2, pp. 440–446, 2012.